关键信息
-
基因名
DEPDC1B
- 应用
-
别名
DEPDC1B; XTP8; DEP domain-containing protein 1B; HBV X-transactivated gene 8 protein; HBV XAg-transactivated protein 8
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WUY9
-
表达区间
1-529aa
-
氨基酸序列
MEHRIVGPGP YRATRLWNET VELFRAKMPL RKHRCRFKSY EHCFTAAEAV DWLHELLRCS QNFGPEVTRK QTVQLLKKFL KNHVIEDIKG KWGEEDFEDN RHLYRFPPSS PLKPYPKKPP NQKDVIKFPE WNDLPPGTSQ ENIPVRPVVM NSEMWYKRHS IAIGEVPACR LVHRRQLTEA NVEEIWKSMT LSYLQKILGL DSLEEVLDVK LVNSKFIIHN VYSVSKQGVV ILDDKSKELP HWVLSAMKCL ANWPNCSDLK QPMYLGFEKD VFKTIADYYG HLKEPLLTFH LFDAFVSVLG LLQKEKVAVE AFQICCLLLP PENRRKLQLL MRMMARICLN KEMPPLCDGF GTRTLMVQTF SRCILCSKDE VDLDELLAAR LVTFLMDNYQ EILKVPLALQ TSIEERVAHL RRVQIKYPGA DMDITLSAPS FCRQISPEEF EYQRSYGSQE PLAALLEEVI TDAKLSNKEK KKKLKQFQKS YPEVYQERFP TPESAALLFP EKPKPKPQLL MWALKKPFQP FQRTRSFRM
-
分子量
61.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
DEPDC1B (DEP domain containing 1B) is a protein that has garnered interest in scientific research due to its potential roles in cell proliferation, differentiation, and tumorigenesis. Existing studies suggest that DEPDC1B may be involved in regulating key signaling pathways, especially in the context of cancer biology where aberrant expression levels are often observed. The significance of DEPDC1B in various malignancies proposes that it could serve as a biomarker for cancer progression or a therapeutic target. Recent advancements in biochemistry have facilitated the recombinant expression of DEPDC1B, allowing researchers to produce this protein in a controlled laboratory setting for detailed study. The generation of recombinant DEPDC1B is crucial for elucidating its biological functions and interactions with other molecular players within the cell. Understanding the structural and functional properties of DEPDC1B through recombinant technologies can provide insights into its role in oncogenesis and tissue homeostasis, ultimately paving the way for potential clinical applications in cancer diagnostics and therapeutics. By synthesizing and characterizing this protein, researchers aim to unlock its molecular mechanisms and contribute to the broader knowledge surrounding cancer biology, with aspirations of translating findings into meaningful healthcare solutions.
